Literature DB >> 33970677

HDAC Inhibition in the Heart: Erasing Hidden Fibrosis.

Thomas G Gillette1.   

Abstract

Entities:  

Keywords:  Editorials; heart failure; histone deacetylases

Mesh：

Substances：

Year:  2021        PMID： 33970677      PMCID： PMC8162936          DOI： 10.1161/CIRCULATIONAHA.121.054262

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  15 in total

1.  Histone deacetylase inhibition blunts ischemia/reperfusion injury by inducing cardiomyocyte autophagy.

Authors:  Min Xie; Yongli Kong; Wei Tan; Herman May; Pavan K Battiprolu; Zully Pedrozo; Zhao V Wang; Cyndi Morales; Xiang Luo; Geoffrey Cho; Nan Jiang; Michael E Jessen; John J Warner; Sergio Lavandero; Thomas G Gillette; Aslan T Turer; Joseph A Hill
Journal:  Circulation       Date:  2014-01-06       Impact factor: 29.690

Review 2.  Readers, writers, and erasers: chromatin as the whiteboard of heart disease.

Authors:  Thomas G Gillette; Joseph A Hill
Journal:  Circ Res       Date:  2015-03-27       Impact factor: 17.367

3.  Suppression of class I and II histone deacetylases blunts pressure-overload cardiac hypertrophy.

Authors:  Yongli Kong; Paul Tannous; Guangrong Lu; Kambeez Berenji; Beverly A Rothermel; Eric N Olson; Joseph A Hill
Journal:  Circulation       Date:  2006-05-30       Impact factor: 29.690

4.  Histone deacetylase activity governs diastolic dysfunction through a nongenomic mechanism.

Authors:  Mark Y Jeong; Ying H Lin; Sara A Wennersten; Kimberly M Demos-Davies; Maria A Cavasin; Jennifer H Mahaffey; Valmen Monzani; Chandrasekhar Saripalli; Paolo Mascagni; T Brett Reece; Amrut V Ambardekar; Henk L Granzier; Charles A Dinarello; Timothy A McKinsey
Journal:  Sci Transl Med       Date:  2018-02-07       Impact factor: 17.956

Review 5.  Targeting inflammation in heart failure with histone deacetylase inhibitors.

Authors:  Timothy A McKinsey
Journal:  Mol Med       Date:  2011-01-20       Impact factor: 6.354

6.  Inhibition of histone deacetylation blocks cardiac hypertrophy induced by angiotensin II infusion and aortic banding.

Authors:  Hae Jin Kee; Il Suk Sohn; Kwang Il Nam; Jong Eun Park; Yong Ri Qian; Zhan Yin; Youngkeun Ahn; Myung Ho Jeong; Yung-Jue Bang; Nacksung Kim; Jong-Keun Kim; Kyung Keun Kim; Jonathan A Epstein; Hyun Kook
Journal:  Circulation       Date:  2005-12-27       Impact factor: 29.690

7.  Class II histone deacetylases act as signal-responsive repressors of cardiac hypertrophy.

Authors:  Chun Li Zhang; Timothy A McKinsey; Shurong Chang; Christopher L Antos; Joseph A Hill; Eric N Olson
Journal:  Cell       Date:  2002-08-23       Impact factor: 41.582

8.  Nitrosative stress drives heart failure with preserved ejection fraction.

Authors:  Gabriele G Schiattarella; Francisco Altamirano; Dan Tong; Kristin M French; Elisa Villalobos; Soo Young Kim; Xiang Luo; Nan Jiang; Herman I May; Zhao V Wang; Theodore M Hill; Pradeep P A Mammen; Jian Huang; Dong I Lee; Virginia S Hahn; Kavita Sharma; David A Kass; Sergio Lavandero; Thomas G Gillette; Joseph A Hill
Journal:  Nature       Date:  2019-04-10       Impact factor: 49.962

9.  HDAC inhibition improves cardiopulmonary function in a feline model of diastolic dysfunction.

Authors:  Markus Wallner; Deborah M Eaton; Remus M Berretta; Laura Liesinger; Matthias Schittmayer; Juergen Gindlhuber; Jichuan Wu; Mark Y Jeong; Ying H Lin; Giulia Borghetti; Sandy T Baker; Huaqing Zhao; Jessica Pfleger; Sandra Blass; Peter P Rainer; Dirk von Lewinski; Heiko Bugger; Sadia Mohsin; Wolfgang F Graier; Andreas Zirlik; Timothy A McKinsey; Ruth Birner-Gruenberger; Marla R Wolfson; Steven R Houser
Journal:  Sci Transl Med       Date:  2020-01-08       Impact factor: 19.319

10.  HDAC Inhibition Reverses Preexisting Diastolic Dysfunction and Blocks Covert Extracellular Matrix Remodeling.

Authors:  Joshua G Travers; Sara A Wennersten; Brisa Peña; Rushita A Bagchi; Harrison E Smith; Rachel A Hirsch; Lauren A Vanderlinden; Ying-Hsi Lin; Evgenia Dobrinskikh; Kimberly M Demos-Davies; Maria A Cavasin; Luisa Mestroni; Christian Steinkühler; Charles Y Lin; Steven R Houser; Kathleen C Woulfe; Maggie P Y Lam; Timothy A McKinsey
Journal:  Circulation       Date:  2021-03-08       Impact factor: 29.690
View more
  2 in total

Review 1.  Targeting the cytoskeleton and extracellular matrix in cardiovascular disease drug discovery.

Authors:  Bohdan B Khomtchouk; Yoon Seo Lee; Maha L Khan; Patrick Sun; Deniel Mero; Michael H Davidson
Journal:  Expert Opin Drug Discov       Date:  2022-03-08       Impact factor: 7.050

2.  Epigenetic Regulation of Heart Failure: Cell Type Matters.

Authors:  Stephanie L Padula; Katherine E Yutzey
Journal:  Circ Res       Date:  2021-07-22       Impact factor: 23.213
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.